Yahoo! Finance: THRX NewsCopyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=thrxLatest Financial News for Theravance, Inc.en-usTue, 15 Dec 2009 12:04:08 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifYahoo! Financehttp://finance.yahoo.com14417THERAVANCE INC Files SEC form 8-K, Other Events (EDGAR Online)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/thrx8-k.htmlyahoo_finance/404710776Tue, 15 Dec 2009 12:04:08 Etc/GMTGilead Gets the Experts on Its Side (at Motley Fool)http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12tantsbm/*http%3A//www.fool.com/investing/general/2009/12/11/gilead-gets-the-experts-on-its-side.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2597589466Fri, 11 Dec 2009 19:08:14 Etc/GMTSeth Klarman's Biggest Bets (at Investopedia)http://us.rd.yahoo.com/finance/external/investopedia/rss/SIG=13ul0pdoc/*http%3A//stocks.investopedia.com/stock-analysis/2009/Seth-Klarmans-Biggest-Bets-PDLI-NWS-FACT-ENZN-THRX-LINTA-BRK.A1208.aspx?partner=YahooSAyahoo_finance/2440384866Tue, 8 Dec 2009 18:25:32 Etc/GMTTheravance to Present at the Deutsche Bank 2009 Biotech Boston Confab (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091202/0564808.html?.v=1yahoo_finance/146033417Wed, 2 Dec 2009 21:05:00 Etc/GMTTheravance Announces New Employment Inducement Awards (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091201/0564776.html?.v=1yahoo_finance/3321576878Wed, 2 Dec 2009 00:00:00 Etc/GMTFDA Denies Approval of Theravance Pneumonia Drug (at Fox Business)http://us.rd.yahoo.com/finance/external/FoxBusiness.com/rss/SIG=13if4181t/*http%3A//www.foxbusiness.com/story/markets/industries/health-care/fda-denies-approval-theravance-pneumonia-drug/yahoo_finance/3433220253Mon, 30 Nov 2009 21:45:04 Etc/GMTThe FDA Moves the Goalposts (at Motley Fool)http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12p72vvth/*http%3A//www.fool.com/investing/high-growth/2009/11/30/the-fda-moves-the-goalposts.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3930654538Mon, 30 Nov 2009 19:14:47 Etc/GMTBioMed Updates: Merck KGaA, BioMarin, Cytori and Theravance (at Seeking Alpha)http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=133ffdlme/*http%3A//seekingalpha.com/article/175777-biomed-updates-merck-kgaa-biomarin-cytori-and-theravance?source=yahooyahoo_finance/3988381314Mon, 30 Nov 2009 19:10:32 Etc/GMTBiotech Stocks: Drug stocks split; Theravance slides on setback (at MarketWatch)http://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12oo1in4o/*http%3A//www.marketwatch.com/news/story/drug-stocks-split-theravance-slides/story.aspx?guid=%7BDB807FA9%2D2C7E%2D4AB8%2D91BF%2DAA25A383B0DA%7D&siteid=yhoofShares of Theravance fall on news that U.S. regulators have refused to approve its pneumonia treatment telavancin until they receive more supporting information on the product.yahoo_finance/3457209133Mon, 30 Nov 2009 18:22:00 Etc/GMTPicks of the Week: Microsoft, H-P, Goldman, TiVo (at BusinessWeek)http://us.rd.yahoo.com/finance/news/rss/story/*http://us.rd.yahoo.com/finance/editorial/xbizwk/SIG=12e7ti2vq/*http%3A//www.businessweek.com/investor/content/nov2009/pi20091127_523028.htm?campaign_id=yhooyahoo_finance/2908574624Mon, 30 Nov 2009 13:08:48 Etc/GMTTheravance Announces That EMEA Has Completed the Validation Phase for the Telavancin MAA for the Treatment of Nosocomial Pneumonia and Complicated Skin and Soft Tissue Infections (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091130/0563622.html?.v=1yahoo_finance/131847118Mon, 30 Nov 2009 12:00:00 Etc/GMTUPDATE - FDA denies approval for Theravance's pneumonia drug (at Reuters)http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh69751_2009-11-27_19-53-16_bng375698_newsml&rpc=44&type=marketsNewsyahoo_finance/4050239638Fri, 27 Nov 2009 19:53:16 Etc/GMTTheravance says FDA delays new Vitabiv decision (AP)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091127/us_theravance_vibativ.html?.v=1Theravance Inc. said Friday the Food and Drug Administration delayed a decision on whether to approve its infection drug Vitabiv as a treatment for hospital-acquired pneumonia.yahoo_finance/2111144247Fri, 27 Nov 2009 19:45:41 Etc/GMTTHERAVANCE INC Files SEC form 8-K, Other Events (EDGAR Online)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091127/thrx8-k.htmlyahoo_finance/3090593884Fri, 27 Nov 2009 19:15:53 Etc/GMTTheravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091127/0563434.html?.v=1yahoo_finance/1271680645Fri, 27 Nov 2009 18:30:00 Etc/GMTTheravance, Inc.: Wait to Buy on Dip (at Seeking Alpha)http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12cdd4old/*http%3A//seekingalpha.com/article/175439-theravance-inc-wait-to-buy-on-dip?source=yahooyahoo_finance/1481231080Thu, 26 Nov 2009 11:19:08 Etc/GMTUnique Strategy Generates Big Returns for Baupost (Indie Research)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091113/2535_id.html?.v=1Though typically described as a value investor, Seth Klarman's strategy - and his remarkable track record - are difficult to define.yahoo_finance/3730835059Fri, 13 Nov 2009 13:52:00 Etc/GMTTHERAVANCE INC Financials (EDGAR Online Financials)http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=thrxyahoo_finance/3985541782Tue, 10 Nov 2009 14:04:42 Etc/GMTTheravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States (Marketwire)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091105/0555982.html?.v=1yahoo_finance/3517718710Thu, 5 Nov 2009 21:05:00 Etc/GMTTHERAVANCE INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091104/thrx10-q.htmlyahoo_finance/3901152808Wed, 4 Nov 2009 21:47:32 Etc/GMT